Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7836753rdf:typepubmed:Citationlld:pubmed
pubmed-article:7836753lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:7836753lifeskim:mentionsumls-concept:C0023516lld:lifeskim
pubmed-article:7836753lifeskim:mentionsumls-concept:C0524637lld:lifeskim
pubmed-article:7836753lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:7836753lifeskim:mentionsumls-concept:C0221284lld:lifeskim
pubmed-article:7836753lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:7836753lifeskim:mentionsumls-concept:C0033681lld:lifeskim
pubmed-article:7836753lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:7836753lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:7836753pubmed:issue4lld:pubmed
pubmed-article:7836753pubmed:dateCreated1995-2-27lld:pubmed
pubmed-article:7836753pubmed:abstractTextThe YTA-1 anti-LFA-1 alpha mAb activates protein tyrosine kinase (PTK), augments NK cytotoxicity, and induces proliferation of fresh CD3- large granular lymphocytes. We demonstrate here that LFA-1 is physically associated in the YT human NK-like cell line cells with a PTK(s) that is distinct from Src family PTKs such as Lck, Fyn, or Lyn. In vitro kinase assays revealed similar association of protein kinase activity with LFA-1 in normal CD3- large granular lymphocytes. Tyrosine phosphorylation of the proteins associated with LFA-1 drastically increased in YT cells after stimulation with NK-sensitive K562 cells but not with NK-resistant P815 cells. Furthermore, pretreatment of YT cells with TS1/22 anti-LFA-1 alpha and TS1/18 anti-LFA-1 beta mAbs abrogated not only the cytotoxicity against K562 cells but also an increase in tyrosine phosphorylation of LFA-1-associated molecules induced by K562 stimulation. These results provide biochemical evidence that the PTK(s) associated with LFA-1 is involved in the signal transduction that follows the recognition of NK target cells.lld:pubmed
pubmed-article:7836753pubmed:languageenglld:pubmed
pubmed-article:7836753pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7836753pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7836753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7836753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7836753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7836753pubmed:statusMEDLINElld:pubmed
pubmed-article:7836753pubmed:monthFeblld:pubmed
pubmed-article:7836753pubmed:issn0022-1767lld:pubmed
pubmed-article:7836753pubmed:authorpubmed-author:KawakamiTTlld:pubmed
pubmed-article:7836753pubmed:authorpubmed-author:UchidaAAlld:pubmed
pubmed-article:7836753pubmed:authorpubmed-author:MinamiYYlld:pubmed
pubmed-article:7836753pubmed:authorpubmed-author:SugieKKlld:pubmed
pubmed-article:7836753pubmed:issnTypePrintlld:pubmed
pubmed-article:7836753pubmed:day15lld:pubmed
pubmed-article:7836753pubmed:volume154lld:pubmed
pubmed-article:7836753pubmed:ownerNLMlld:pubmed
pubmed-article:7836753pubmed:authorsCompleteYlld:pubmed
pubmed-article:7836753pubmed:pagination1691-8lld:pubmed
pubmed-article:7836753pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:7836753pubmed:meshHeadingpubmed-meshheading:7836753-...lld:pubmed
pubmed-article:7836753pubmed:meshHeadingpubmed-meshheading:7836753-...lld:pubmed
pubmed-article:7836753pubmed:meshHeadingpubmed-meshheading:7836753-...lld:pubmed
pubmed-article:7836753pubmed:meshHeadingpubmed-meshheading:7836753-...lld:pubmed
pubmed-article:7836753pubmed:meshHeadingpubmed-meshheading:7836753-...lld:pubmed
pubmed-article:7836753pubmed:meshHeadingpubmed-meshheading:7836753-...lld:pubmed
pubmed-article:7836753pubmed:meshHeadingpubmed-meshheading:7836753-...lld:pubmed
pubmed-article:7836753pubmed:meshHeadingpubmed-meshheading:7836753-...lld:pubmed
pubmed-article:7836753pubmed:meshHeadingpubmed-meshheading:7836753-...lld:pubmed
pubmed-article:7836753pubmed:meshHeadingpubmed-meshheading:7836753-...lld:pubmed
pubmed-article:7836753pubmed:meshHeadingpubmed-meshheading:7836753-...lld:pubmed
pubmed-article:7836753pubmed:year1995lld:pubmed
pubmed-article:7836753pubmed:articleTitleStimulation of NK-like YT cells via leukocyte function-associated antigen (LFA)-1. Possible involvement of LFA-1-associated tyrosine kinase in signal transduction after recognition of NK target cells.lld:pubmed
pubmed-article:7836753pubmed:affiliationDepartment of Late Effect Studies, Kyoto University, Japan.lld:pubmed
pubmed-article:7836753pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7836753pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7836753lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7836753lld:pubmed